Drug Type Synthetic peptide |
Synonyms ImmTher, disaccharide tripeptide glycerol dipalmitoyl |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ewing Sarcoma | Phase 2 | United States | 01 Sep 1998 | |
Ewing Sarcoma | Phase 2 | United States | 01 Sep 1998 |
Phase 2 | 46 | (Arm A: VACdxr With ImmTher) | xtyaohgnos(lnuwttbzst) = gbhbxqikkj lrgehioxhq (oaukaoqzsb, pnvybfyaqy - hmewdxsxic) View more | - | 29 Jan 2020 | ||
(Arm B: VACdxr) | xtyaohgnos(lnuwttbzst) = npyllgfvmn lrgehioxhq (oaukaoqzsb, wesplnfrsl - pppssmhbgt) View more |